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[θ], 1000xdeg.cm 2 dmol -1 Figure S2 . Folding of XRCC4 p.Trp43Arg differs from XRCC4 WT . Mean residue ellipticity [θ] plotted against wavelength. Red line indicates XRCC4 p.Trp43Arg , blue line is XRCC4 WT . Circular dichroism was undertaken as follows -both XRCC4 and XRCC4 p.Trp43Arg samples were buffer exchanged to 10 mM NaH 2 PO4 pH 8 using Bio-spin 6 columns (Bio-rad). CD data were collected using an Aviv 410 spectropolarimeter and a 1 mm pathlength quartz cuvette. Protein concentrations for XRCC4 and XRCC4 p.Trp43Arg were 0.117 and 0.112 mg/ml respectively. CD spectra were recorded at 4°C, measured between wavelength 260 and 190 nm with 0.5 nm wavelength step, 1 sec averaging time and 3 runs per sample. Raw data was averaged, subtracted of buffer signal, and smoothed. Mean residue ellipticity [θ] was then calculated. . The concentrations of XRCC4/LIG4 and XRCC4 Trp43Arg /LIG4 were increased 2-fold from 10 nM as indicated. 116 bp dsDNA labelled with 6-FAM was PCR-amplified from LIG4 and BsaI digested to generate a cohesive overhang 5′-TCGA -3′ on one side of the product. (B) DNA ligation of blunt-ended DNA ends by XRCC4/LIG4. 25 nM of Ku70/80 was incubated with 25 nM of XRCC4/LIG4 or XRCC4 Trp43Arg /LIG4 as indicated. pcDNA3.1(-) was linearized with EcoRV. 10 nM of the 6-FAM labelled substrate or 50 ng of the linearized plasmid was incubated with proteins indicated in figure legends in 20 µl of a ligation buffer (25 mM Tris-HCl pH 7.5, 150 mM KCl, 1 mM MgCl 2 , 1 mM DTT, 10% (w/v) PEG 10,000) at 37 ºC for 30 min. The reaction was stopped by 10 mM EDTA and 0.01% (w/v) SDS, and the samples were incubated at 50 ºC for 30 min after adding 20 µg/ml Proteinase K. The samples were then applied into 5% polyacrylamide gel for the 6-FAM-labelled substrate and visualized using Typhoon 9000 (GE Healthcare), or into 0.8% agarose gel and stained with SYBR Gold (Life Technologies) and visualised using a UV imager.
XRCC4 WT /LIG4
DNA Ligation products Figure S4 . RT-PCR analysis demonstrates a splicing defect in XRCC4 transcripts in P5. P5 is compound heterozygous for c.25delC, p.His9Thrfs*8 and c.-10-1G>T. The latter mutation is predicted to disrupt the splice acceptor site of exon 2. RNA was therefore extracted from P5 fibroblasts using the RNeasy Mini Kit (Qiagen). Complimentary DNA (cDNA) was then generated from 1 ug template RNA by reverse transcription (AMV RT, Roche) using random oligonucleotides. The reaction was also performed in the absence of RT (substituted with RNase-free H 2 O) to ensure contamination with genomic DNA had not occurred during the generation of cDNA. Exons 1-4 of XRCC4 were amplified (primer sequences and PCR conditions available upon request) from both control and P5 RNA and the resulting PCR product subjected to agarose gel electrophoresis and visualised with a UV imager.
RT-PCR on RNA from P5 fibroblasts indicates that exon 2, containing the ATG initiation codon, is spliced out of the transcript. Table S2 . Extended flow cytometric analysis of peripheral blood lymphocyte populations in XRCC4-MPD individuals.
Bold -values below reference range.
